Offshore Appraisal Section 1782 Proceedings
Section 1782 discovery proceedings for dissenting shareholders pursuing billions of dollars in offshore shareholder appraisal claims, including in connection with the take-private mergers of 58.com, SINA, LINE Corp., 51Jobs.com, Myovant Sciences, Innoplexus, and New Frontier Health.
Kaisa Group Holdings
Representing Oasis Management as the holder of New York law governed bonds issued by Kaisa, a China-based property conglomerate in default on billions of dollars in international obligations.
EpiPen Antitrust Litigation
Multidistrict class-action litigation on behalf of purchasers forced to overpay for life-saving EpiPens, leading to settlements of more than $600 million for EpiPen purchasers.
Generic Drug Price-Fixing Litigation
Represented a major healthcare company as an opt-out plaintiff in multidistrict class action litigation over price-fixing allegations covering more than a hundred generic drugs in In re Generic Drug Price-Fixing Litigation.
Louisiana Trigger Ban Litigation
High-impact constitutional litigation in Louisiana following the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization, including securing the first ruling in the nation to block the implementation of a state’s unconstitutionally vague “trigger bans” following Dobbs.
* Includes matters handled prior to joining Pallas Partners (US) LLP.
